CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research
Ovarian cancer diagnostics company, Cleo Diagnostics Limited (ASX:COV) (CLEO, or the Company) is pleased to announce the appointment of international Contract Research
/THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED
Highlights Crawford on track for mid-2025 construction decision and first production by year-end 2027 Front End Engineering Design led
Lancaster Resources Inc. (CSE:LCR | OTCQB:LANRF | FRA:6UF0) (‘ Lancaster’ or the ‘ Company ‘ ) a North American critical minerals exploration
White Cliff Minerals Limited (White Cliff or the Company) is pleased to provide an update on planned work at its various projects
As the market for digital assets continues to grow, investors are looking for new ways to gain exposure to cryptocurrencies, and one
Investing in oil stocks can be a lucrative endeavor, but determining the right time to enter a sector known for volatile swings
The world’s population is increasing rapidly and is expected to reach over 9.7 billion by 2050. This situation is creating positive fundamentals
Lithium Universe Limited (referred to as ‘Lithium Universe’ or the ‘Company,’ ASX: ‘LU7’) provides a strategic update on addressing the gap in